FDAの医薬品および医療機器規制に関する医療専門家学生の知識
Kiranjot K Sangha1, Rita F Redberg2, Aaron S Kesselheim3
1K.K. Sangha was a medical student, University of California San Francisco, San Francisco, California, at the time of this writing and is now a resident physician, Department of Medicine, University of California Irvine, Irvine, California.
まとめ
最後の年の医療専門家の学生は,食品医薬品局 (FDA) の規制と臨床試験の解釈の理解が不十分であることを示しています. 薬や医療機器に関する患者のケア決定を 改善するために,これらの重要なテーマに関する教育を 強化する必要があります.
科学分野:
- 医学教育
- 規制科学
- 臨床研究
背景:
- 医療従事者は,食品医薬品局 (FDA) が規制する医薬品や医療機器を頻繁に利用しています.
- FDAの承認プロセスを理解し,臨床試験のデータを解釈することは,患者のケアに不可欠です.
- 既存の医学と薬学のカリキュラムでは,これらのトピックに関する教育が提案されていますが,学生の知識は評価されていません.
研究 の 目的:
- FDAの規制と臨床研究の証拠の解釈に関する健康専門家の最終年の学生の知識を評価する.
- 将来の医療従事者の間でFDAの承認要件と臨床試験の質に関する理解のギャップを特定する.
主な方法:
- 24項目の調査は,FDAの承認プロセスに対する学生の自己評価,証拠要件の理解,および試験データを解釈する能力を評価するために開発されました.
- この調査は カリフォルニア大学サンフランシスコ校の 医学,薬学,看護学専攻の 333人の最終学年の学生全員に実施された.
- データは2024年1月から4月にかけて175人の回答者から収集された (53%の回答率).
主要な成果:
- 回答者の71%はFDAの医薬品承認に関する教育を受けたが,90%は基本的または素早いと説明し,58%はさらなる教育を求めている.
- 医療機器の承認について教えたのは14%だけだった.
- 38%がFDAの薬剤承認に関する理解を中等から優れたものとして評価したにもかかわらず,承認基準を正しく特定したのは3%のみで,全原因死亡のエンドポイントの優位性を認識したのは17%でした.
結論:
- 医療専門家の学生はFDAの承認プロセスと新しい医療製品の証拠の質について限られた理解を示しています.
- 規制科学と臨床試験の解釈に関する教育カリキュラムを 強化する必要があることは明らかです
- 改善された教育により 将来の臨床医は 根拠に基づいた決定を下し 医療製品について 患者と効果的にコミュニケーションをとることができます
関連する概念動画
01:25Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
241
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
241
01:19Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
01:16Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K